Haemonetics Corp (HAE)
71.48
+0.32
(+0.45%)
USD |
NYSE |
Nov 01, 16:00
71.45
-0.03
(-0.04%)
After-Hours: 20:00
Haemonetics Enterprise Value: 4.537B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 4.537B |
| October 31, 2024 | 4.521B |
| October 30, 2024 | 4.565B |
| October 29, 2024 | 4.620B |
| October 28, 2024 | 4.755B |
| October 25, 2024 | 4.746B |
| October 24, 2024 | 4.759B |
| October 23, 2024 | 4.630B |
| October 22, 2024 | 4.690B |
| October 21, 2024 | 4.711B |
| October 18, 2024 | 4.776B |
| October 17, 2024 | 4.766B |
| October 16, 2024 | 4.747B |
| October 15, 2024 | 4.727B |
| October 14, 2024 | 4.732B |
| October 11, 2024 | 4.716B |
| October 10, 2024 | 4.689B |
| October 09, 2024 | 4.774B |
| October 08, 2024 | 4.803B |
| October 07, 2024 | 4.830B |
| October 04, 2024 | 4.865B |
| October 03, 2024 | 4.875B |
| October 02, 2024 | 4.938B |
| October 01, 2024 | 4.922B |
| September 30, 2024 | 4.993B |
| Date | Value |
|---|---|
| September 27, 2024 | 4.963B |
| September 26, 2024 | 4.797B |
| September 25, 2024 | 4.722B |
| September 24, 2024 | 4.743B |
| September 23, 2024 | 4.788B |
| September 20, 2024 | 4.709B |
| September 19, 2024 | 4.722B |
| September 18, 2024 | 4.749B |
| September 17, 2024 | 4.796B |
| September 16, 2024 | 4.806B |
| September 13, 2024 | 4.773B |
| September 12, 2024 | 4.628B |
| September 11, 2024 | 4.587B |
| September 10, 2024 | 4.663B |
| September 09, 2024 | 4.601B |
| September 06, 2024 | 4.627B |
| September 05, 2024 | 4.696B |
| September 04, 2024 | 4.717B |
| September 03, 2024 | 4.721B |
| August 30, 2024 | 4.747B |
| August 29, 2024 | 4.737B |
| August 28, 2024 | 4.722B |
| August 27, 2024 | 4.804B |
| August 26, 2024 | 4.794B |
| August 23, 2024 | 4.781B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.777B
Minimum
Jan 27 2022
7.209B
Maximum
Feb 08 2021
4.741B
Average
4.737B
Median
Aug 29 2024
Enterprise Value Benchmarks
| Boston Scientific Corp | 131.03B |
| Baxter International Inc | 29.17B |
| Teleflex Inc | 11.32B |
| Cerus Corp | 290.88M |
| Insulet Corp | 17.10B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 38.37M |
| Revenue (Quarterly) | 336.17M |
| Total Expenses (Quarterly) | 296.42M |
| EPS Diluted (Quarterly) | 0.74 |
| Gross Profit Margin (Quarterly) | 52.03% |
| Profit Margin (Quarterly) | 11.41% |
| Earnings Yield | 3.12% |
| Operating Earnings Yield | 4.33% |
| Normalized Earnings Yield | 3.288 |